Kinase 2016: Next Generation Inhibitors

16 - 17 May 2016, Nottingham, United Kingdom


Perturbation of cell signalling through inhibition of kinase enzymes has delivered nearly 30 approved medicines to date. The seventh SCI/RSC symposium on kinase inhibitor design will feature several highly pertinent themes including new approaches and technologies to modulate and measure kinase function as well as diverse medicinal chemistry case studies. The symposium will also draw on the lessons from history to provide insight into the future direction of the field.


In addition to medicinal discovery scientists wishing to further their knowledge of kinases, the meeting will also be of great value to the wider drug discovery community. It will provide transferable lessons and insight into how new approaches and technologies are being applied in a successful and maturing field of research.

Call for Poster Abstracts:

Abstracts for poster presentations are now invited. Those presenting may also elect to advertise their poster via oral presentation of a single slide ‘flash’ poster. Please send a maximum one page abstract to with the subject line "Kinase 2016 – poster submission" by Friday 18 March 2016.


An exhibition will run alongside the conference during refreshment breaks, for companies and related organisations who may wish to exhibit. For further information and prices please email


BioCity, BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF, United Kingdom

Organised by
Organising Committee John Harris, SCI/CJH Consultants UK Simon Peace, SCI/GlaxoSmithKline Sarah Rook, SCI/Evotec (UK) Ltd Pascal Savy, SCI/Charles River Laboratories Mihiro Sunose, RSC/Sygnature Discovery Martin Swarbrick, RSC/Cancer Research Technology Andrew Thomas, SCI/AstraZeneca
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry